TB500 5mg Vial
Peptide for Research Use Only
$50.00$30.00
Key Potential Benefits (Primarily from Preclinical and Limited Human Data)
Accelerated Wound Healing and Tissue Repair
Promotes faster re-epithelialization, collagen deposition, and contraction in skin wounds (e.g., rat models showed 42-61% faster closure).
Phase II human trials with topical full-length Tβ4 showed benefits for chronic wounds like venous stasis ulcers, pressure ulcers, and epidermolysis bullosa, with accelerated repair and good tolerability.
Supports healing in other tissues, including corneal/eye injuries and infected wounds.
Muscle, Tendon, Ligament, and Soft Tissue Recovery
Enhances cell migration, angiogenesis (new blood vessel formation), and actin dynamics for better tissue remodeling.
Animal studies (e.g., rat Achilles tendon transection or medial collateral ligament injury) demonstrate improved biomechanical strength, reduced scar tissue, and faster functional recovery.
Often reported to aid post-injury or post-surgical recovery in muscles, tendons, and ligaments, with improved flexibility and reduced downtime.
Reduced Inflammation
Exhibits anti-inflammatory effects by modulating cytokine responses and immune cell activity.
May help with chronic inflammation in joints, muscles, or other sites, contributing to pain relief and better mobility in injury models.
Cardiovascular and Organ Protection
Preclinical data suggest cardiac repair after ischemia/hypoxia (e.g., improved myocyte survival and function post-myocardial infarction in mice).
Potential for protecting/repairing heart, liver, kidney, or neural tissue in injury models, including neuroprotective effects after stroke or trauma.
Other Emerging or Speculative Benefits
Improved hair regrowth (via follicle stimulation in some models).
Enhanced flexibility/mobility and reduced fibrosis.
Synergistic effects when combined with peptides like BPC-157 for broader regenerative support.
Some research explores "embryonic-like" regenerative states for anti-aging or organ recovery.
These effects stem from TB-500/Tβ4's mechanisms: promoting cell proliferation/migration, angiogenesis, actin regulation, and dampening excessive inflammation without broad immunosuppression.
